CLINICAL_TRIALS
ClinicalTrials.gov record update
Trial to Determine the CR Rate at the Primary Tumor Site After 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head & Neck Carcinoma Treated With Definitive Concurrent Cisplatin & Radiation Therapy
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00736944
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:02.149647+00:00
- Published At
- 2014-01-07T00:00:00+00:00
- Record Updated At
- 2020-09-09
- Results Posted At
- 2014-01-07
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Squamous Cell Carcinoma of the Head and Neck"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-09-09"- protocolSection.identificationModule.nctId
"NCT00736944"- protocolSection.identificationModule.officialTitle
"Trial to Determine the CR Rate at the Primary Tumor Site After 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, \u0026 5-FU for Advanced Head \u0026 Neck Carcinoma Treated With Definitive Concurrent Cisplatin \u0026 Radiation Therapy"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-01-07"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.